The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
A maresin 1/RORα/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis
Open accessAbstract
Retinoic acid-related orphan receptor α (RORα) is considered a key regulator of polarization in liver macrophages that is closely related to nonalcoholic steatohepatitis (NASH) pathogenesis. However, hepatic microenvironments that support the function of RORα as a polarity regulator were largely unknown. Here, we identified maresin 1 (MaR1), a docosahexaenoic acid (DHA) metabolite with a function of specialized proresolving mediator, as an endogenous ligand of RORα. MaR1 enhanced the expression and transcriptional activity of RORα and thereby increased the M2 polarity of liver macrophages. Administration of MaR1 protected mice from high-fat diet-induced NASH in a RORα-dependent manner. Surprisingly, RORα increased the level of MaR1 through transcriptional induction of 12-lipoxygenase (12-LOX), a key enzyme in MaR1 biosynthesis. Furthermore, we demonstrated that modulation of 12-LOX activity enhanced the protective function of DHA against NASH. Together, these results suggest that the MaR1/RORα/12-LOX autoregulatory circuit could offer potential therapeutic strategies for curing NASH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“At least some of these lipid metabolites are produced by macrophages (101) and also signal to macrophages to reduce inflammatory and fibrogenic gene expression (102).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [102]
In the citing paper
“A maresin 1/ RAR-related orphan receptor alpha (RORα)/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of MASH (102).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [102]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murray, P. J. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034339 · Cited by 2,981
Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M. (2010) · Cell · doi:10.1016/j.cell.2010.07.041 · Cited by 2,428
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338
Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages
Huang, S. C., Everts, B., Ivanova, Y., O’Sullivan, D., Nascimento, M., Smith, A. M., Beatty, W. L., Love-Gregory, L. D., Lam, W. Y., O’Neill, C. M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2956 · Cited by 1,256
Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035
Maresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions
Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., & Spite, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081880 · Cited by 908
Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
Buckley, C. D., Gilroy, D. W., & Serhan, C. N. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.009 · Cited by 839
Jetten, A. M. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07003 · Cited by 700
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–155 of 155
Roles of heterogenous hepatic macrophages in the progression of liver diseases
Lee, K., Kim, M., & Han, Y. (2022) · BMB Reports · doi:10.5483/bmbrep.2022.55.4.022 · Cited by 12
Self-citationMaresin1: A multifunctional regulator in inflammatory bone diseases
Zhang, Z., Ji, C., Wang, M., Wang, M., She, X., Song, D., Xu, X., & Zhang, D. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110308 · Cited by 13
Gao, R., Zhang, X., Zhou, Z., Sun, J., Tang, X., Li, J., Zhou, X., & Shen, T. (2022) · Disease Markers · doi:10.1155/2022/7251450 · Cited by 10
Liang, T., Qiu, J., Li, S., Deng, Z., Qiu, X., Hu, W., Li, P., Chen, T., Liang, Z., Zhou, H., et al. (2021) · Mediators of Inflammation · doi:10.1155/2021/9954909 · Cited by 10
Specialized pro-resolving mediator Maresin 1 attenuates pain in a mouse model of osteoarthritis
Shih, Y.-R. V., Tao, H., Gilpin, A., Lee, Y., Perikamana, S. M., & Varghese, S. (2024) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2024.10.018 · Cited by 9
Self-citationZhuang, P., Wu, Y., Yao, J., Liu, X., Liu, H., Wan, X., Jia, W. P., Wang, T., Zhang, Y., & Jiao, J. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102128 · Cited by 11
Liu, L., Qian, S., Li, W., Dong, S., Ya, R., He, Y., Huang, H., Chen, Y., Ma, N., Hao, Y., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.06.022 · Cited by 9
Maresin1 can be a potential therapeutic target for nerve injury
Wang, X., Botchway, B. O. A., Zhang, Y., Huang, M., & Liu, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114466 · Cited by 10
Resolving inflammation in nonalcoholic steatohepatitis
Spite, M. R. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127583 · Cited by 9
Sulforaphane ameliorates non-alcoholic steatohepatitis by KLF4-mediated macrophage M2 polarization
Huang, X., Xu, J., Xu, Y., Huangfu, B., Zhang, F., Hu, Y., Gao, R., Ren, X., Zhang, B., Huang, K., et al. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250220 · Cited by 8
The methyltransferase MLL4 promotes nonalcoholic steatohepatitis by enhancing NF-κB signaling
Lee, J., An, H., Kim, C.-S., & Lee, S. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107984 · Cited by 8
Huang, S., Zeng, J., Sun, R., Yu, H. Y., Zhang, H., Su, X., & Yao, P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.840398 · Cited by 8
Brown Adipose Tissue Activation in Humans Increases Plasma Levels of Lipid Mediators
Walker, M. E., Kodani, S. D., Mena, H. A., Tseng, Y., Cypess, A. M., & Spite, M. R. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae016 · Cited by 8
Feng, G., Liao, Z., Wang, Y., Tang, Q., Li, N., Cheng, L., Liu, Y., Liu, R., Cui, M., Fan, W., et al. (2025) · Bone Research · doi:10.1038/s41413-025-00445-w · Cited by 6
Mori, Y., Kawakami, Y., Kanzaki, K., Otsuki, A., Kimura, Y., Kanji, H., Tanaka, R., Tsukayama, I., Hojo, N., Suzuki-Yamamoto, T., et al. (2020) · The Journal of Biochemistry · doi:10.1093/jb/mvaa062 · Cited by 6
RORα autoregulates its transcription via MLL4-associated enhancer remodeling in the liver
Han, Y., Kim, H., Choi, H., Lee, S., & Lee, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118007 · Cited by 6
Self-citationShang, L., Ma, H., Zhang, X., Mao, R., Ma, C., & Ruan, Z. (2023) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13757 · Cited by 6
Choi, H., Oh, D., Kim, H., Chambugong, M., Kim, M., Lee, M., & Park, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122443 · Cited by 6
Self-citationLiver injury after small bowel resection is prevented in obesity-resistant 129S1/SvImJ mice
Onufer, E. J., Han, Y., Courtney, C. M., Steinberger, A. E., Tecos, M. E., Sutton, S., Sescleifer, A. M., Ou, J., Czepielewski, R. S., Randolph, G. J., et al. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00284.2020 · Cited by 6
Self-citationMaresins: The Mainstay in Periodontal Resolution
Gireddy, H., Rajaram, H., Koduganti, R. R., Ambati, M., Anilkumar, R., & Harika, T. S. L. (2022) · Cureus · doi:10.7759/cureus.21742 · Cited by 6
Sun, X., Feng, Y., Zhao, Y., Cai, Y., Cao, Z., Zhang, Y., Wei, Z., Du, A., & Xu, B. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag017 · Cited by 6
Exploring the Role of Polyunsaturated Fatty Acids in Children’s Sleep
Zhu, L., Zhu, B., & Yao, D. (2025) · Biomedicines · doi:10.3390/biomedicines13092045 · Cited by 4
Jetten, A. M., Beak, J. Y., Slominski, A. T., & Jensen, B. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-78315-0_14 · Cited by 4
Development of novel liver-targeting glucocorticoid prodrugs
Wang, Y., Guo, D., Winkler, R., Lei, X., Wang, X., Messina, J. M., Luo, J., & Lü, H. (2023) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2023.100172 · Cited by 3
Fatty acid mediators and the inflammasome
Desmarais, F., Bergeron, K., Ntambi, J. M., Rassart, É., & Mounier, C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00011-7 · Cited by 3
Yoon, J.-Y., Kim, J., Kim, H., Ka, N., Lee, S.-H., & Lee, M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121254 · Cited by 3
Self-citationHerrera Vielma, F., Quiñones San Martin, M., Muñoz-Carrasco, N., Berrocal-Navarrete, F., Herrada, A. A., Olate-Briones, A., Zagmutt, S., Rodríguez-Rodríguez, R., González, D. R., & Zúñiga-Hernandez, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1826739 · Cited by 2
He, C., Liu, Y., Lv, K., An, Z., Xue, C., & Dong, N. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116876 · Cited by 2
Therapeutic Activity of Resolvin D1 (RvD1) in Murine MASHPreprint
Navarro‐Corcuera, A., Zhu, Y., Ma, F., Gupta, N., Asplund, H., Yuan, F., Friedman, S., Sansbury, B. E., Huang, X. H., & Cai, B. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.22.590633 · Cited by 2
Orphan Nuclear Receptors in Metabolic Dysfunction-associated Steatotic Liver Disease Development
Li, H., Chen, J., Huang, Z., & Chen, M. (2025) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2025.00019 · Cited by 1
Hwang, I., Lee, S. W., Kim, H. J., Kim, Y., & Lee, S. W. (2025) · Life · doi:10.3390/life15091410 · Cited by 1
Self-citationDesmarais, F., Maltais, R., Sancéau, J., Marcotte, B., Guèvremont, G., Trottier, J., Mitchell, P. L., Barbier, O., Poirier, D., & Marette, A. (2025) · The FASEB Journal · doi:10.1096/fj.202502152rrrr · Cited by 1
Zhao, Y., Zhang, J., Fan, X., Cai, Y., Du, W., Yu, Z., Xu, B., & Sun, X. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.172162 · Cited by 1
Potter, A. M., Burton, L. H., Santangelo, K. S., Nordgren, T. M., & Sikes, K. J. (2026) · Arthritis Research & Therapy · doi:10.1186/s13075-026-03757-2 · Cited by 1
Qiu, C., Xian, W., Wang, M., Zhao, G., Zhang, Y., Zhou, Z., Sheng, B., Zhen, Z., Liu, X., Diao, S., et al. (2026) · Advanced Science · doi:10.1002/advs.202520748 · Cited by 1
Non-coding RNAs Related to Lipid Metabolism and Non-alcoholic Fatty Liver Disease
Holvoet, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-68844-8_4 · Cited by 1
Kashyap, H., Kumari, J., & Khatri, M. (2025) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2025-0146
Lipoxygenase expression and oxylipin analysis in human THP-1 monocyte-derived macrophages
Sofia, A., Mauricio, M., Rubbo, H., & González-Perilli, L. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110647
Li, T., Cai, H., Qiu, C., Zhang, J., Zhou, S., Zhu, P., & Xian, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1712761
Wei, J., Su, W., Zhao, Y., Wei, Z., Hua, Y., Xue, P., Zhu, X., Chen, Y., & Chen, G. (2022) · Figshare · doi:10.6084/m9.figshare.19112835
Tang, D., Fu, G., Li, W., Sun, P., Loughran, P., Deng, M., Scott, M. J., & Billiar, T. R. (2021) · Figshare · doi:10.6084/m9.figshare.14121752
Wei, J., Su, W., Zhao, Y., Wei, Z., Hua, Y., Xue, P., Zhu, X., Chen, Y., & Chen, G. (2022) · Figshare · doi:10.6084/m9.figshare.19112829
Wei, J., Su, W., Zhao, Y., Wei, Z., Hua, Y., Xue, P., Zhu, X., Chen, Y., & Chen, G. (2022) · Figshare · doi:10.6084/m9.figshare.19112838
Wei, J., Su, W., Zhao, Y., Wei, Z., Hua, Y., Xue, P., Zhu, X., Chen, Y., & Chen, G. (2022) · Figshare · doi:10.6084/m9.figshare.19112826
TBBPA facilitates splenic inflammation and pyroptosis by targeting HMGB1
Jiang, F.-W., Lin, J.-H., Wang, J.-X., Chen, M. S., Liu, S., Zhu, H.-M., Shi, Y.-S., Lou, M., Hu, Z.-Y., Zhao, Y., et al. (2026) · Journal of Environmental Sciences · doi:10.1016/j.jes.2026.01.072
Kouti, T., Christodoulou, P., Christodoulides, S., Protopapa, F., Michaeloudes, C., & Farazi, P. A. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1767917
RORα: a critical nexus in the crosstalk between cholesterol metabolism and macrophage polarization
Li, D., Liu, G., Wen, X., Zhang, G., Liu, K., Yuan, L., Yu, B., & An, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1831854
Restoration of circadian rhythm as novel targets against sarcopenia
Wang, T., & Hong, Z. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004087
Lotfi, R., Nasirifar, A., Rahmani, H., Falahi, S., & Kashiri, M. (2026) · Health Science Reports · doi:10.1002/hsr2.73012
戸田, 桂., Tamai, R., Tanaka, R., Araki, N., Ishihara, M., Kanji, H., Tsukayama, I., Kawakami, Y., Suzuki-Yamamoto, T., & Takahashi, Y. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2026.159768
Huangfu, B., Xu, J., Huang, X., Huang, K., He, X., & Zhai, B. (2026) · ACS Nutrition Science · doi:10.1021/acsnutrsci.6c00050
Kotlyarov, S. (2026) · Studies in natural products chemistry · doi:10.1016/b978-0-443-51068-7.00014-3
Martin, M. Q. S., Olivera-Fuentes, C., Vielma, F. H., Norambuena-González, R., Solís-Céspedes, E., González, D. R., Perera-Sardiña, Y., & Zúñiga‐Hernández, J. (2026) · Biomolecules · doi:10.3390/biom16111558
Millar, B., Godson, C., & de Gaetano, M. (2026) · Current topics in microbiology and immunology · doi:10.1007/82_2026_367
Disrupted Resolution Mechanisms in the Onset and Progression of Chronic Liver Disease
Clãria, J., Romero-Grimaldo, B., Contreras, B. J., Sánchez-Rodríguez, M. B., Rojano, C., Titos, E., & López‐Vicario, C. (2026) · Current topics in microbiology and immunology · doi:10.1007/82_2026_365
Metadata
- Authors
- Han, Y.-H., Shin, K.-O., Kim, J.-Y., Khadka, D. B., Kim, H.-J., Lee, Y.-M., Cho, W.-J., Cha, J.-Y., Lee, B.-J., & Lee, M.-O.
- Affiliations
- Seoul National University (KR)
- Chungbuk National University (KR)
- Chonnam National University (KR)
- Gachon University (KR)
- Corresponding author
- Lee, Mi-Ock
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2019-03-11
- Volume
- 129
- Issue
- 4
- Pages
- 1684-1698
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC6436872
- OpenAlex
- W2921132259
- Cited by
- 154
- References
- 56
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 11 · 2023: 24 · 2022: 37 · 2021: 30 · 2020: 14 · 2019: 5
- FWCI
- 16.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- The National Research Foundation of Korea (2017R1A2B3011870, 2018R1A5A2024425)
- Korea Mouse Phenotyping Project (NRF-2014M3A9D5A01073556)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- maresin 1, RORα, 12-lipoxygenase, nonalcoholic steatohepatitis, specialized pro-resolving mediators, docosahexaenoic acid metabolites, M2 macrophages, high-fat diet-induced liver injury, inflammation resolution, therapeutic target
- MeSH terms
- Animals, Arachidonate 12-Lipoxygenase, Dietary Fats, Docosahexaenoic Acids, Humans, Inflammation, Macrophages, Male, Mice, Knockout, Mice, Nuclear Receptor Subfamily 1, Group F, Member 1, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review